Core Viewpoint - The company, Blue Biological (603739), has received approval from the Ministry of Agriculture and Rural Affairs for its new veterinary drug, "Oxidized Amine Iodine Solution," which is classified as a Class III new veterinary drug and is intended for disinfection in farming environments [1] Group 1 - The approval includes a registration certificate for the new veterinary drug [1] - The new product is developed in collaboration with the company's wholly-owned subsidiary, Qingdao Kangdian Animal Pharmaceutical Co., Ltd., and other units [1]

Core Viewpoint - The company, Blue Biological (603739), has received approval for its new veterinary drug "Oxytetracycline Iodine Solution" as a Class III new veterinary drug, with the issuance of the "New Veterinary Drug Registration Certificate" [1] Group 1 - The company and its wholly-owned subsidiary, Qingdao Kangdian Animal Pharmaceutical Co., Ltd., jointly applied for the approval of the new veterinary drug [1] - The approval signifies a significant milestone for the company in expanding its product offerings in the veterinary medicine sector [1]

Core Viewpoint - The company, Weilan Bio (603739.SH), has received approval from the Ministry of Agriculture and Rural Affairs for its new veterinary drug, "Oxidized Amine Iodine Solution," which is classified as a Class III new veterinary drug and is intended for disinfection in breeding environments [1]. Group 1 - The approval was granted based on the review of relevant regulations, including the "Veterinary Drug Management Regulations" and the "Veterinary Drug Registration Measures" [1]. - The new veterinary drug registration certificate was issued recently, as indicated by the Ministry of Agriculture and Rural Affairs announcement No. 970 [1]. - The product is developed by the company and its wholly-owned subsidiary, Qingdao Kangdian Animal Pharmaceutical Co., Ltd., in collaboration with other entities [1].

Core Viewpoint - The company, Blue Biological (603739.SH), announced that its wholly-owned subsidiary, Qingdao Kangdian Animal Pharmaceutical Co., Ltd., along with other units, has received approval for "Oxytetracycline Iodine Solution" as a Class III new veterinary drug, and has recently been issued a "New Veterinary Drug Registration Certificate" [1] Company Summary - Blue Biological has successfully obtained regulatory approval for a new veterinary drug, indicating progress in its product development pipeline [1] - The approval of the new veterinary drug may enhance the company's market position and expand its product offerings in the veterinary pharmaceutical sector [1] Industry Summary - The approval of new veterinary drugs is significant for the industry, as it reflects ongoing innovation and regulatory compliance within the veterinary pharmaceutical market [1] - The introduction of Class III new veterinary drugs can potentially lead to increased competition and improved animal health solutions in the market [1]